Es gab 50 kürzliche Insider-Transaktionen für MediciNova, Inc. (MNOV), darunter 35 Käufe und 11 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $14.79M und die gesamten Insider-Verkäufe auf $824.22K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Iwaki Yuichi, Matsuda Kazuko, Nagao Hideki. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — MNOV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-16 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
450,000 |
$2.10 |
$945K |
450,000 |
| 2026-01-16 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
350,000 |
$2.10 |
$735K |
350,000 |
| 2025-06-17 |
Nagao Hideki |
Director |
RSU-Zuteilung |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-06-17 |
Beaver Carolyn |
Director |
RSU-Zuteilung |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-06-17 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-02-12 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
100,000 |
$1.84 |
$184K |
100,000 |
| 2025-02-12 |
Nagao Hideki |
Director |
RSU-Zuteilung |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-02-12 |
Beaver Carolyn |
Director |
RSU-Zuteilung |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-02-12 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
100,000 |
$1.84 |
$184K |
100,000 |
| 2025-02-12 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-01-07 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
400,000 |
$1.52 |
$608K |
400,000 |
| 2025-01-07 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$1.52 |
$456K |
300,000 |
| 2024-06-11 |
Nagao Hideki |
Director |
RSU-Zuteilung |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-06-11 |
Beaver Carolyn |
Director |
RSU-Zuteilung |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-06-11 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-01-09 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
210,000 |
$2.40 |
$504K |
210,000 |
| 2024-01-09 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
157,500 |
$2.40 |
$378K |
157,500 |
| 2024-01-09 |
Obrien Geoffrey |
Vice President |
RSU-Zuteilung |
84,000 |
$2.40 |
$201.6K |
84,000 |
| 2023-08-04 |
Lemerond Nicole |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-08-04 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
18,333 |
$2.47 |
$45.28K |
18,333 |
| 2023-06-13 |
Nagao Hideki |
Director |
RSU-Zuteilung |
20,000 |
$2.23 |
$44.6K |
20,000 |
| 2023-06-13 |
Beaver Carolyn |
Director |
RSU-Zuteilung |
20,000 |
$2.23 |
$44.6K |
20,000 |
| 2023-01-23 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
235,125 |
- |
- |
235,125 |
| 2023-01-23 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
149,625 |
- |
- |
149,625 |
| 2023-01-23 |
Obrien Geoffrey |
Vice President |
RSU-Zuteilung |
76,950 |
- |
- |
76,950 |
| 2022-11-28 |
Nagao Hideki |
Director |
Informierter Verkauf |
6,754 |
$2.25 |
$15.2K |
- |
| 2022-11-22 |
Nagao Hideki |
Director |
Informierter Verkauf |
218 |
$2.13 |
$464.34 |
6,754 |
| 2022-11-21 |
Nagao Hideki |
Director |
Informierter Verkauf |
5,365 |
$2.18 |
$11.7K |
6,972 |
| 2022-11-17 |
Nagao Hideki |
Director |
Informierter Verkauf |
309 |
$2.18 |
$673.62 |
12,337 |
| 2022-06-16 |
Nagao Hideki |
Director |
RSU-Zuteilung |
20,000 |
- |
- |
20,000 |
| 2022-06-16 |
Beaver Carolyn |
Director |
RSU-Zuteilung |
20,000 |
$2.51 |
$50.2K |
20,000 |
| 2022-06-16 |
Kruger Jason J |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-01-27 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
302,500 |
$5.92 |
$1.79M |
302,500 |
| 2022-01-27 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
192,500 |
$5.92 |
$1.14M |
192,500 |
| 2022-01-27 |
Obrien Geoffrey |
Vice President |
RSU-Zuteilung |
99,000 |
$5.92 |
$586.08K |
99,000 |
| 2021-08-23 |
Matsuda Kazuko |
Chief Medical Officer |
Optionsausübung (Verkauf) |
60,000 |
$2.30 |
$138K |
- |
| 2021-08-01 |
Paulin Douglas |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-07-09 |
Iwaki Yuichi |
President and CEO |
Optionsausübung (Verkauf) |
39,583 |
$2.54 |
$100.54K |
- |
| 2021-06-24 |
Matsuda Kazuko |
Chief Medical Officer |
Optionsausübung (Verkauf) |
56,250 |
$2.46 |
$138.38K |
- |
| 2021-06-16 |
Nagao Hideki |
Director |
RSU-Zuteilung |
20,000 |
$3.95 |
$79K |
20,000 |
| 2021-06-16 |
Beaver Carolyn |
Director |
RSU-Zuteilung |
20,000 |
$3.95 |
$79K |
20,000 |
| 2021-05-19 |
Obrien Geoffrey |
Vice President |
Optionsausübung (Verkauf) |
32,000 |
$2.54 |
$81.28K |
- |
| 2021-04-22 |
Gaeta Federico C.a. |
Chief Scientific Officer |
Veräußerung |
20,000 |
$5.42 |
$108.4K |
- |
| 2021-04-22 |
Gaeta Federico C.a. |
Chief Scientific Officer |
RSU-Zuteilung |
24,000 |
$4.56 |
$109.44K |
24,000 |
| 2021-03-11 |
Nagao Hideki |
Director |
Informierter Verkauf |
2,354 |
$7.40 |
$17.42K |
12,646 |
| 2021-02-25 |
Iwaki Yuichi |
President and CEO |
Optionsausübung (Verkauf) |
86,250 |
$2.46 |
$212.18K |
- |
| 2021-02-02 |
Iwaki Yuichi |
President and CEO |
RSU-Zuteilung |
495,000 |
$6.89 |
$3.41M |
495,000 |
| 2021-02-02 |
Matsuda Kazuko |
Chief Medical Officer |
RSU-Zuteilung |
325,000 |
$6.89 |
$2.24M |
325,000 |
| 2021-02-02 |
Obrien Geoffrey |
Vice President |
RSU-Zuteilung |
99,000 |
$6.89 |
$682.11K |
99,000 |
| 2021-01-11 |
3d Investment Partners Pte. Ltd. |
10 Percent Owner |
Unbekannt |
456,637 |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
